Filing excerpt
Biogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the second quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $164 million on a pre-tax basis.
Source: Autobound Signal API · 76 signals tracked for Biogen · updated
Get Biogen's live signals in Claude or ChatGPT, or by API
What changed at Biogen this week? Use Autobound signals for biogen.com.Biogen is allocating significant capital for external innovation, with up to $484 million earmarked for acquiring R&D assets and funding collaboration agreements.
Filing excerpt
Biogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the second quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $164 million on a pre-tax basis.
What this signalsIntegration work after a deal often opens needs for new systems and services.
sec-8kacquisitionAnnouncedGet every 8-K signal for Biogen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/d99ef0a2-269f-48f1-b3c9-e957a62b66eb returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.
{
"signal_id": "d99ef0a2-269f-48f1-b3c9-e957a62b66eb",
"signal_type": "sec-8k",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-07-07T07:08:01.618+00:00",
"company": {
"name": "Biogen",
"domain": "biogen.com"
},
"data": {
"detail": "Biogen is allocating significant capital for external innovation, with up to $484 million earmarked for acquiring R&D assets and funding collaboration agreements. This major investment creates opportunities for vendors supporting M&A integration, clinical development, and R&D portfolio management.",
"metrics": {
"timeframe": "next_quarter",
"dollar_context": "Maximum expected expense for acquired in-process research and development, upfront payments, and milestones across Q2 and Q3 2026 ($164M in Q2 + up to $320M in Q3).",
"dollar_millions": 484
},
"summary": "Biogen to spend up to $484M on R&D acquisitions and licensing deals in Q2 & Q3 2026",
"excerpts": "Biogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the second quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $164 million on a pre-tax basis.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000068/biib-20260701.htm",
"filing_date": "2026-07-01",
"filing_year": 2026,
"fiscal_year_end": "07/01",
"sales_relevance": "Integration needs coming",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/d99ef0a2-269f-48f1-b3c9-e957a62b66eb \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"biogen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.